Among other biomarkers, serum CA-125, a glycoprotein of ∼200 to 5,000 kDa, has been employed routinely and is approved by the FDA for early epithelial ovarian cancer detection (Tripathi et al., 2020a). The gene discussed is MUC16; the disease is ovarian carcinoma.